
pmid: 25150563
Body dysmorphic disorder (BDD) can be a severe and often debilitating psychiatric disorder that has been largely under-recognized and underdiagnosed. Pharmacologic and nonpharmacologic treatment options are available but limited. This review aims to provide an updated overview of the psychopathology and epidemiology of BDD, with an emphasis on current pharmacologic and nonpharmacologic treatment options for BDD.
Obsessive-Compulsive Disorder, Cognitive Behavioral Therapy, Comorbidity, Patient Acceptance of Health Care, Body Dysmorphic Disorders, Combined Modality Therapy, Delusions, Suicide, Humans, Selective Serotonin Reuptake Inhibitors
Obsessive-Compulsive Disorder, Cognitive Behavioral Therapy, Comorbidity, Patient Acceptance of Health Care, Body Dysmorphic Disorders, Combined Modality Therapy, Delusions, Suicide, Humans, Selective Serotonin Reuptake Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
